investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Influence of germ line genetic variation on myeloma progression and survival

Elad Ziv

5 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Nicola J Camp

University of Utah

Salt Lake City, United States

Shaji K Kumar

Mayo Clinic (Rochester)

Rochester, United States

Celine M Vachon

Mayo Clinic (Rochester)

Rochester, United States

Elad Ziv

University of California, San Francisco

San Francisco, United States

Related projects

Jens G Lohr

Determining the mutational landscape of circulating multiple myeloma cells

Multiple myeloma and immunoproliferative diseases

Pathology

Catriona HM Jamieson

(PQC2) Niche-responsive RNA editing by ADAR1 in dormant multiple myeloma initiating cell maintenance

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Conor C Lynch

Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Jetze J Tepe

Characterization of Non-Competitive Proteasome Binding

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Ralph D Sanderson

Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies